OTT-166
- Generic Name
- OTT-166
Nesvategrast (OTT166) in Diabetic Retinopathy (DR)
- First Posted Date
- 2022-06-08
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- OcuTerra Therapeutics, Inc.
- Target Recruit Count
- 225
- Registration Number
- NCT05409235
- Locations
- 🇺🇸
Clinical Site 163, Baltimore, Maryland, United States
🇺🇸Clinical Site 145, Baltimore, Maryland, United States
🇺🇸Clinical Site 120, Cleveland, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath